3. Seifert V, Gasser T, Senft C (2011) Low field intraoperative MRI in glioma surgery. ACTA NEUROCHIR SUPPL, 109: 35-41
4. Vatter H, Konczalla J, Seifert V (2011) Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? ACTA NEUROCHIR SUPPL, 110 (Pt 1):
177-80 Supplement
1. Senft C, Bink A, Heckelmann M, Gasser T, Seifert V (2011) Glioma extent of resection and ultra-low-field iMRI: interim analysis of a prospective randomized trial. ACTA NEUROCHIR SUPPL, 109: 49-53
Fallbericht
1. Schuss P, Ulrich CT, Harter PN, Tews DS, Seifert V, Franz K (2011) Gliosarcoma with bone infiltration and extracranial growth: case report and review of literature. J NEURO-ONCOL, 103 (3): 765-70
2. Seifert V, Güresir E, Vatter H (2011) Exclusively intradural exposure and clip reconstruction in complex paraclinoid aneurysms. ACTA NEUROCHIR, 153 (11): 2103-9
Dissertation
1. Delic O (2011) Beitrag der Protonen-Magnetresonanzspektroskopie (1H-MRS) zur Diagnostik und Prognose von Patienten mit WHO Grad II und Grad III Gliomen.
2. Droste C (2011) Ergebnisse nach operativer Entfernung lumbaler Synovialzysten - eine unizentrische Studie -.
3. Balzer-Geldsetzer M, Braga da Costa ASF, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R (2011) Parkinson's Disease and Dementia: A Longitudinal Study (DEMPARK). NEUROEPIDEMIOLOGY, 37 (3-4): 168-76
4. Baudrexel S, Witte T, Seifried C, von Wegner F, Beissner F, Klein JC, Steinmetz H, Deichmann R, Roeper J, Hilker R (2011) Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease. NEUROIMAGE, 55 (4): 1728-38 5. Becktepe JS, You SJ, Berkefeld J, Neumann-Haefelin T, Singer OC (2011) Clinical outcome
after mechanical recanalization as mono- or adjunctive therapy in acute stroke: importance of time to recanalization. CEREBROVASC DIS, 32 (3): 211-8
6. Beissner F, Deichmann R, Baudrexel S (2011) fMRI of the brainstem using dual-echo EPI.
NEUROIMAGE, 55 (4): 1593-9
7. Bevan S, Meidtner K, Lorenz M, Sitzer M, Grant PJ, Markus HS (2011) Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness. STROKE, 42 (6): 1510-4
8. Bink A, Berkefeld J, Kraus L, Senft C, Ziemann U, du Mesnil de Rochemont R (2011) Long-term outcome in patients treated for benign dural arteriovenous fistulas of the posterior fossa.
NEURORADIOLOGY, 53 (7): 493-500
9. Blasel S, Pfeilschifter W, Jansen V, Mueller K, Zanella F, Hattingen E (2011) Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. J NEUROL, 258 (1): 113-22
10. Boehncke S, Ackermann H, Badenhoop K, Sitzer M (2011) Pituitary function and IGF-I levels following ischemic stroke. CEREBROVASC DIS, 31 (2): 163-169
11. Brockmann K, Gröger A, Di Santo A, Liepelt I, Schulte C, Klose U, Maetzler W, Hauser AK, Hilker R, Gomez-Mancilla B, Berg D, Gasser T (2011) Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers. MOVEMENT DISORD, 26 (13): 2335-42
12. Brodbeck V, Spinelli L, Lascano AM, Wissmeier M, Vargas MI, Vulliemoz S, Pollo C, Schaller K, Michel CM, Seeck M (2011) Electroencephalographic source imaging: a prospective study of 152 operated epileptic patients. BRAIN, 134 (10): 2887-97
13. Cash RFH, Ziemann U, Thickbroom GW (2011) Inhibitory and disinhibitory effects on I-wave facilitation in motor cortex. J NEUROPHYSIOL, 105 (1): 100-6
14. Conde L, Bevan S, Sitzer M, Klopp N, Illig T, Thiery J, Seissler J, Baumert J, Raitakari O, Kähönen M, Lyytikäinen LP, Laaksonen R, Viikari J, Lehtimäki T, Koernig W, Halperin E, Markus HS (2011) Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling.
ATHEROSCLEROSIS, 219 (2): 684-9
15. Daniels C, Krack P, Volkmann J, Raethjen J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G, Witt K (2011) Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? MOVEMENT DISORD, 26 (14): 2516-21
16. Elbaz A, Ross OA, Ioannidis JPA, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Krüger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilariño-Güell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ (2011) Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. ANN NEUROL, 69 (5):
778-92
17. Gracien R, Kordulla M, Ziemann U (2011) Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis. MULT SCLER, 17 (4): 498-500
18. Hattingen E, Magerkurth J, Pilatus U, Hübers A, Wahl M, Ziemann U (2011) Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis. NMR BIOMED, 24 (5): 536-46
19. Henke C, Beissner F (2011) [Illustrations of visceral referred pain. "Head-less" Head's zones].
SCHMERZ, 25 (2): 132-6, 138-9
20. Hilker R, Antonini A, Odin P (2011) What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus? J NEURAL TRANSM, 118 (6): 907-14
21. Hilker R, Brotchie JM, Chapman J (2011) Pros and cons of a prion-like pathogenesis in Parkinson's disease. BMC NEUROL, 11: 74
22. Hoche F, Balikó L, den Dunnen W, Steinecker K, Bartos L, Sáfrány E, Auburger G, Deller T, Korf HW, Klockgether T, Rüb U, Melegh B (2011) Spinocerebellar ataxia type 2 (SCA2):
identification of early brain degeneration in one monozygous twin in the initial disease stage.
CEREBELLUM, 10 (2): 245-53
23. Iadecola C, Kahles T, Gallo EF, Anrather J (2011) Neurovascular protection by ischaemic tolerance: role of nitric oxide. J PHYSIOL-LONDON, 589 (17): 4137-45
24. Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Dürr A, Marelli C, Globas C, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hübsch T, Fancellu R, Mariotti C, Tomasello C, Baliko L, Melegh B, Filla A, Rinaldi C, van de Warrenburg BP, Verstappen CCP, Szymanski S, Berciano J, Infante J, Timmann D, Boesch S, Hering S, Depondt C, Pandolfo M, Kang JS, Ratzka S, Schulz J, Tezenas du Montcel S, Klockgether T (2011) The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. NEUROLOGY, 77 (11): 1035-41
25. Kang JS, Jochem-Gawehn S, Laufs H, Ferbert A, Vieregge P, Ziemann U (2011) [Hirayama disease in Germany: case reports and review of the literature]. NERVENARZT, 82 (10):
1264-72
26. Kang JS, Terranova C, Hilker R, Quartarone A, Ziemann U (2011) Deficient Homeostatic Regulation of Practice-Dependent Plasticity in Writer's Cramp. CEREB CORTEX, 21 (5):
1203-12
27. Kell CA, Morillon B, Kouneiher F, Giraud AL (2011) Lateralization of Speech Production Starts in Sensory Cortices--A Possible Sensory Origin of Cerebral Left Dominance for Speech. CEREB CORTEX, 21 (4): 932-7
28. Klein JC, Lorenz B, Kang JS, Baudrexel S, Seifried C, van de Loo S, Steinmetz H, Deichmann R, Hilker R (2011) Diffusion tensor imaging of white matter involvement in essential tremor. HUM BRAIN MAPP, 32 (6): 896-904
29. Kleinschnitz C, Blecharz K, Kahles T, Schwarz T, Kraft P, Göbel K, Meuth SG, Burek M, Thum T, Stoll G, Förster C (2011) Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. STROKE, 42 (4): 1081-9
30. Korchounov A, Ziemann U (2011) Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study. BIOL PSYCHIAT, 36 (9): 1894-902 31. Kriváneková L, Lu MK, Bliem B, Ziemann U (2011) Modulation of excitability in human
primary somatosensory and motor cortex by paired associative stimulation targeting the primary somatosensory cortex. EUR J NEUROSCI, 34 (8): 1292-300
32. Kurz A, Rabbani N, Walter M, Bonin M, Thornalley P, Auburger G, Gispert S (2011) Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. CELL MOL LIFE SCI, 68 (4): 721-33
33. Laufs H, Richardson MP, Salek-Haddadi A, Vollmar C, Duncan JS, Gale K, Lemieux L, Löscher W, Koepp MJ (2011) Converging PET and fMRI evidence for a common area involved in human focal epilepsies. NEUROLOGY, 77 (9): 904-10
34. Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, Steinmetz H, Schaffer CB, Lo EH, Foerch C (2011) Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
CIRCULATION, 124 (15): 1654-62
35. Lauer A, Schlunk F, Van Cott EM, Steinmetz H, Lo EH, Foerch C (2011) Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J CEREBR BLOOD F MET, 31 (8): 1736-42
36. Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, de Carvalho M, Meyer T, Tysnes OB, Auburger G, Gispert S, Bonini NM, Andersen PM, Gitler AD (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. HUM MOL GENET, 20 (9):
1697-700
37. Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U (2011) The perfect crime? CCSVI not leaving a trace in MS. J NEUROL NEUROSUR PS, 82 (4): 436-40
38. Morzelewski A, Laufs H (2011) Polysomnographie während funktioneller Magnetresonanztomografie. NEUROPHYSIOL LAB, 33: 70-76
39. Murakami T, Restle J, Ziemann U (2011) Observation-execution matching and action inhibition in human primary motor cortex during viewing of speech-related lip movements or listening to speech. NEUROPSYCHOLOGIA, 49 (7): 2045-54
40. Ni Z, Müller-Dahlhaus F, Chen R, Ziemann U (2011) Triple-pulse TMS to study interactions between neural circuits in human cortex. BRAIN STIMUL, 4 (4): 281-93
41. Pfeilschifter W, Czech-Zechmeister Be, Sujak M, Foerch C, Wichelhaus TA, Pfeilschifter J (2011) Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. EXP TRANSL STROKE MED, 3: 2
42. Pfeilschifter W, Czech-Zechmeister Be, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J (2011) Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. BIOCHEM BIOPH RES CO, 413 (2):
212-7
43. Pfeilschifter W, Spitzer D, Czech-Zechmeister B, Steinmetz H, Foerch C (2011) Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice. STROKE, 42 (4): 1116-21
44. Pfeilschifter W, Spitzer D, Pfeilschifter J, Steinmetz H, Foerch C (2011) Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC. PLOS ONE, 6 (10): e26087
45. Rodríguez-Labrada R, Velázquez-Pérez L, Seigfried C, Canales-Ochoa N, Auburger G, Medrano-Montero J, Sánchez-Cruz G, Aguilera-Rodríguez R, Laffita-Mesa J, Vázquez-Mojena Y, Verdecia-Ramirez M, Motta M, Quevedo-Batista Y (2011) Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions. J NEUROL SCI, 306 (1-2): 103-7
46. Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, Ribai P, Charles P, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Baliko L, Melegh B, Filla A, Salvatore E, van de Warrenburg BPC, Szymanski S, Infante J, Timmann D, Boesch S, Depondt C, Kang JS, Schulz JB, Klopstock T, Lossnitzer N, Löwe B, Frick C, Rottländer D, Schlaepfer TE, Klockgether T (2011) Depression comorbidity in spinocerebellar ataxia. MOVEMENT DISORD, 26 (5): 870-6
47. Sharma M, Maraganore DM, Ioannidis JPA, Riess O, Aasly JO, Annesi G, Abahuni N, Bentivoglio AR, Brice A, Van Broeckhoven C, Chartier-Harlin MC, Destée A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Gispert S, Hattori N, Jasinska-Myga B, Klein C, Lesage S, Lynch T, Lichtner P, Lambert JC, Lang AE, Mellick GD, De Nigris F, Opala G, Quattrone A, Riva C, Rogaeva E, Ross OA, Satake W, Silburn PA, Theuns J, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Gasser T, Krüger R (2011) Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. NEUROBIOL AGING, 32 (11): 2108.e1-5
48. Singer OC, Conrad F, Jahnke K, Hattingen E, Auer H, Steinmetz H (2011) Severe meningoencephalomyelitis due to CNS-Toxocarosis. J NEUROL, 258 (4): 696-8
49. Steinmetz H (2011) [Unruptured intracranial aneurysms]. NERVENARZT, 82 (10): 1343-50 50. Tagliazucchi E, Balenzuela P, Fraiman D, Montoya P, Chialvo DR (2011) Spontaneous
BOLD event triggered averages for estimating functional connectivity at resting state.
NEUROSCI LETT, 488 (2): 158-63
51. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, Kim JS, Breuer L, Singer OC, Warach S, Christensen S, Treszl A, Forkert ND, Galinovic I, Rosenkranz M, Engelhorn T, Köhrmann M, Endres M, Kang DW, Dousset V, Sorensen AG, Liebeskind DS, Fiebach JB, Fiehler J, Gerloff C (2011) DWI-FLAIR mismatch for the identification of patients with acute
ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. LANCET NEUROL, 10 (11): 978-86
52. Thornton R, Vulliemoz S, Rodionov R, Carmichael DW, Chaudhary UJ, Diehl B, Laufs H, Vollmar C, McEvoy AW, Walker MC, Bartolomei F, Guye M, Chauvel P, Duncan JS, Lemieux L (2011) Epileptic networks in focal cortical dysplasia revealed using electroencephalography-functional magnetic resonance imaging. ANN NEUROL, 70 (5): 822-37
53. Tony HP, Burmester G, Schulze-Koops H, Grunke M, Henes J, Kötter I, Haas J, Unger L, Lovric S, Haubitz M, Fischer-Betz R, Chehab G, Rubbert-Roth A, Specker C, Weinerth J, Holle J, Müller-Ladner U, König R, Fiehn C, Burgwinkel P, Budde K, Sörensen H, Meurer M, Aringer M, Kieseier B, Erfurt-Berge C, Sticherling M, Veelken R, Ziemann U, Strutz F, von Wussow P, Meier FMP, Hunzelmann N, Schmidt E, Bergner R, Schwarting A, Eming R, Hertl M, Stadler R, Schwarz-Eywill M, Wassenberg S, Fleck M, Metzler C, Zettl U, Westphal J, Heitmann S, Herzog AL, Wiendl H, Jakob W, Schmidt E, Freivogel K, Dörner T (2011) Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID). ARTHRITIS RES THER, 13 (3): R75 54. Velázquez-Pérez L, Voss U, Rodríguez-Labrada R, Auburger G, Canales Ochoa N, Sánchez Cruz G, Galicia Polo L, Haro Valencia R, Aguilera Rodríguez R, Medrano Montero J, Laffita Mesa JM, Tuin I (2011) Sleep disorders in spinocerebellar ataxia type 2 patients.
NEURODEGENER DIS, 8 (6): 447-54
55. Völkers M, Weidenhammer C, Herzog N, Qiu G, Spaich K, von Wegner F, Peppel K, Müller OJ, Schinkel S, Rabinowitz JE, Hippe HJ, Brinks H, Katus HA, Koch WJ, Eckhart AD, Friedrich O, Most P (2011) The inotropic peptide ARKct improves AR responsiveness in normal and failing cardiomyocytes through G( )-mediated L-type calcium current disinhibition. CIRC RES, 108 (1): 27-39
56. Wahl M, Hübers A, Lauterbach-Soon B, Hattingen E, Jung P, Cohen LG, Ziemann U (2011) Motor callosal disconnection in early relapsing-remitting multiple sclerosis. HUM BRAIN MAPP, 32 (6): 846-55
57. Wieder N, Fink RHA, Wegner Fv (2011) Exact and approximate stochastic simulation of intracellular calcium dynamics. J BIOMED BIOTECHNOL, 2011: 572492
58. Witt K, Daniels C, Krack P, Volkmann J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G (2011) Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J NEUROL SCI, 310 (1-2): 261-6
59. Yasuno K, Bak rc o lu M, Low SK, Bilgüvar K, Gaál E, Ruigrok YM, Niemelä M, Hata A, Bijlenga P, Kasuya H, Jääskeläinen JE, Krex D, Auburger G, Simon M, Krischek B, Ozturk AK, Mane S, Rinkel GJE, Steinmetz H, Hernesniemi J, Schaller K, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Günel M (2011) Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. P NATL ACAD SCI USA, 108 (49): 19707-12
60. Ziemann U, Wahl M, Hattingen E, Tumani H (2011) Development of biomarkers for multiple sclerosis as a neurodegenerative disorder. PROG NEUROBIOL, 95 (4): 670-85
Review
1. Laufs H (2011) Die Darstellung gesunder und pathologischer Hirnzustände mittels EEG-kombinierter funktioneller Kernspintomografie (EEG-fMRT). KLIN NEUROPHYSIOL, 42:
183-193
2. Oberschmidt C, Hilker R, Kang JS (2011) Neues zu Neurologischen Bewegungsstörungen 2011. AKTUEL NEUROL, 38: 222-233
3. Ziemann U (2011) Transcranial magnetic stimulation at the interface with other techniques: a powerful tool for studying the human cortex. NEUROSCIENTIST, 17 (4): 368-81
Fallbericht
1. Heidegger T, Ziemann U (2011) Prolongation of central motor conduction time by neck extension in compressive cervical myelopathy. CLIN NEUROPHYSIOL, 122 (9): 1891-3
2. Weber YG, Kamm C, Suls A, Kempfle J, Kotschet K, Schüle R, Wuttke TV, Maljevic S, Liebrich J, Gasser T, Ludolph AC, Van Paesschen W, Schöls L, De Jonghe P, Auburger G, Lerche H (2011) Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
NEUROLOGY, 77 (10): 959-64 Kommentar oder Korrespondenz
1. Auburger G, Kurz A (2011) The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's disease. AGING-US, 3 (1): 5-9
Letter
1. Henke C (2011) Response to the article of Ernst et al. Acupuncture: does it alleviate pain and are there serious risks? A review of reviews. [Pain 2011;152:755-64]. PAIN, 152 (9): 2183-4;
auther reply 2184-6 Dissertation
1. Hagenburger D (2011) Die Triplestimulation zur Untersuchung der zentralen motorischen Leitung: Normwerte bei gesunden Probanden und Befunde bei Patienten mit Multipler Sklerose korreliert mit dem Grad ihrer Behinderung"".
2. Hölig S (2011) Risikoabschätzung für das Auftreten Thrombolyse-assoziierter intrazerebraler Blutungen mittels MRT.
3. Nürnberger LM (2011) T1-und T2*- MR-Relaxometrie des Hirnstamms im Frühstadium des idiopathischen Parkinsonsyndroms.
4. Van de Loo, Simone (2011) Subzelluläre Lokalisation von Ataxin-2 am Endoplasmatischen Retikulum.